US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool.
Background Patients and families from culturally and linguistically diverse (CALD) backgrounds face distinct challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback